These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6247524)

  • 1. [Endotoxin in severe liver diseases (author's transl)].
    Iwasaki M; Maruyama I; Ikeziri N; Abe M; Maeyama T; Nagata E; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Mar; 77(3):386-94. PubMed ID: 6247524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver diseases and endotoxin. I. Endotoxin in various liver diseases (author's transl)].
    Iwasaki M; Maruyama I; Ikeziri N; Abe M; Maeyama T; Nagata E; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):239-48. PubMed ID: 220442
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassay of alpha-fetoprotein. II. Studies in patients suffering from hepatic diseases.
    Delmont J; Kermarec J; Lafon J; Bonet C; Cassuto JP; Masseyeff R
    Digestion; 1974; 10(1):29-39. PubMed ID: 4136258
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum apoprotein A-I and A-II levels in liver diseases and cholestasis.
    Fujii S; Koga S; Shono T; Yamamoto K; Ibayashi H
    Clin Chim Acta; 1981 Sep; 115(3):321-31. PubMed ID: 6271423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guanine deaminase or guanase, the enzyme of hepatic cytolysis. Its diagnostic value in 500 patients].
    Bel A; Dietsch R; Alary R; Savoye B; Levrat R; Nesmoz J; Nyssen M
    Presse Med (1893); 1970 Feb; 78(11):495-9. PubMed ID: 5418623
    [No Abstract]   [Full Text] [Related]  

  • 6. [Passive haemagglutination: a sensitive alpha1-foetoprotein assay (author's transl)].
    Lehmann FG; Lehmann D; Martini GA
    Klin Wochenschr; 1974 Mar; 52(5):216-21. PubMed ID: 4365707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum TBG value in chronic liver diseases and hepatoma with special referrence to microheterogeneity of TBG (author's transl)].
    Miyazaki J; Tanaka N; Iino S; Endo Y
    Horumon To Rinsho; 1982 Feb; 30(2):145-7. PubMed ID: 6177454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical value of the determination of serum 5'nucleotidase. Comparative study with serum alkaline phosphatases].
    Pappo E; Christoforov B; Petite JP; Boulu R; Etienne JP
    Pathol Biol (Paris); 1969 May; 17(9):479-86. PubMed ID: 4308378
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of plasma amino acids levels in liver diseases (author's transl)].
    Morikawa T
    Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2136-43. PubMed ID: 6276597
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of immobilized histidine in assay for endotoxin in patients with liver disease.
    Shiomi S; Kuroki T; Ueda T; Takeda T; Nishiguchi S; Nakajima S; Kobayashi K; Yamagami S; Watanabe T; Minobe S
    J Gastroenterol; 1994 Dec; 29(6):751-5. PubMed ID: 7874271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum glutathione reductase in various clinical conditions, especially in liver diseases.
    Wakui K; Kumata H; Tadaki H; Yamagata S
    Tohoku J Exp Med; 1976 Jan; 118(1):17-23. PubMed ID: 1251442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of serum ferritin in malignant disease (author's transl)].
    Tada A; Aburano T; Tonami N; Hisada K
    Kaku Igaku; 1980 Aug; 17(7):851-5. PubMed ID: 6160274
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of serum immunoglobulins in liver diseases.
    Chen DS; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1976 Apr; 75(4):205-13. PubMed ID: 184236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies of the behavior of PA, RBP in the blood in various liver diseases (author's transl)].
    Shingami T; Morita N; Shiwaku Y; Nakao Y; Hashimoto S
    Igaku Kenkyu; 1979 Sep; 49(3):255-67. PubMed ID: 575752
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H; Beppu T; Seyama Y; Wada T
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of the serum electrolytes sodium and potassium in patients with cholelithiasis with reference to pathologic changes in the liver].
    Schmauss AK; Gerloff D; Poley FW
    Z Gesamte Inn Med; 1971 May; 26(10):327-31. PubMed ID: 5131401
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the cholesterol composition of high-density lipoprotein in chronic liver diseases (author's transl)].
    Takagi Y
    Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1362-8. PubMed ID: 7441912
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum isocitrate dehydrogenase in obstructive jaundice.
    Watts C
    Clin Chim Acta; 1966 Aug; 14(2):177-84. PubMed ID: 5967166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood serum cholesterol fractions in diseases of the liver and biliary tract].
    Shevchenko NG; Sentebova NA; Lupinovich VL; Astaf'eva NI
    Lab Delo; 1979; (7):396-8. PubMed ID: 89227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Summary of a systemic search for alpha-1-feto-protein in 224 hepatic diseases].
    Geffroy Y; Boureille J; Denis P; Colin R; Métayer P
    Sem Hop; 1971 Apr; 47(20):1281-5. PubMed ID: 4326656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.